Clinical trial · Observational
Validation of the MiCK Assay
Mayo Clinic Validation of the MiCK Assay
NCT01770665CI-TRIAL-00023903MiCK AssayterminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Assay being revised and re-validated.
Summary
Brief summary (as posted)
Testing Mayo Clinic cancer patients with the results being correlated with prior patient therapy, performance status, and extent of disease.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mesothelioma, Small Cell Lung Cancer, NSCLC | Malignant Mesothelioma | CURATED_EXACT | 0.85 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Mesothelioma
- label
- all cancer types
Primary outcomes (1)
- measure
- Complete response and survival
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 20 subjects diagnosed with mesothelioma and 10 diagnosed with any malignancy. Exclusion Criteria: * patients that a sample cannot obtained for testing.
References
Publications (0)
Data not yet available
No reference posted for this study.